Verification evidence is still being completed.
PDF / print export
UAB Exolitus
Kaunas, Lithuania
- Verified lead
- Aiste Jekabsone
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Exosome Technology, Immune-Cell Exosome Therapy, and Cosmeceutical Manufacturing
- Review cycle
- 24 April 2026
- Full address
- Savanoriu prospektas 246, Kaunas, Lithuania
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Exolitus official site naming Aiste Jekabsone as CEO.
- Editorial note
- Kaunas LSMU spin-off exosome biotech with named CEO, patented immune-cell exosome therapy for glioblastoma, and A-class Baltic regional certification.
Exosome Technology, Immune-Cell Exosome Therapy, and Cosmeceutical Manufacturing
LSMU spin-off, A-class Okredo and Creditinfo certification, Startup Awards 2022 most innovative
Kaunas LSMU spin-off exosome biotech with named CEO, patented immune-cell exosome therapy for glioblastoma, and A-class Baltic regional certification.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Kaunas LSMU spin-off exosome biotech with named CEO, patented immune-cell exosome therapy for glioblastoma, and A-class Baltic regional certification.
- Lead
- Aiste Jekabsone (verified ↗)
- Address
- Savanoriu prospektas 246, Kaunas, Lithuania (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Exosome manufacturing
- Capabilities
- Exosome Manufacturing from Milk and Cell Cultures · Immune-Cell Exosome Therapy · Cosmeceutical Product Development
- Founded
- 2020
- Headcount
- 1-10
Clinical profileSTATUS: VERIFIED APRIL 2026
Aiste Jekabsone
Chief Executive Officer
Full addressSavanoriu prospektas 246, Kaunas, Lithuania
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
Cosmetic Labs directory listing Exolitus at Savanoriu prospektas 246 in Kaunas.
Open sourceExosome manufacturing
Kaunas, Lithuania. Exosome Technology, Immune-Cell Exosome Therapy, and Cosmeceutical Manufacturing. Review completed on 24 Apr 2026.
Lithuanian State Medicines Control Agency for biomedical development
LSMU spin-off, A-class Okredo and Creditinfo certification, Startup Awards 2022 most innovative
Exosome Technology, Immune-Cell Exosome Therapy, and Cosmeceutical Manufacturing
Kaunas LSMU spin-off exosome biotech with named CEO, patented immune-cell exosome therapy for glioblastoma, and A-class Baltic regional certification.
Editorial note
Exolitus is a Kaunas Lithuanian University of Health Sciences spin-off with a named CEO, patented immune-cell exosome technology for glioblastoma, and A-class Baltic regional certification.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Exosome Manufacturing from Milk and Cell Cultures
Immune-Cell Exosome Therapy
Cosmeceutical Product Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Exosome production workflow
Stimulated immune-cell culture
Cosmeceutical development
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is UAB Exolitus located?
- UAB Exolitus operates from Savanoriu prospektas 246, Kaunas, Lithuania, Kaunas, Lithuania.
- Who runs UAB Exolitus?
- UAB Exolitus is led by Aiste Jekabsone, Chief Executive Officer. Verified 24 Apr 2026.
- What does UAB Exolitus do?
- Kaunas LSMU spin-off exosome biotech with named CEO, patented immune-cell exosome therapy for glioblastoma, and A-class Baltic regional certification. Core capabilities: Exosome Manufacturing from Milk and Cell Cultures, Immune-Cell Exosome Therapy, Cosmeceutical Product Development.
Editorial context
Related technical briefs
Briefs that name Kaunas as a covered market or city.